RE:RE:Big dropwhy did we have a 4.1mm share day mostly into the ask on no news? Maybe it was a pre analyst report bump, buyout speculation, partnership speculation, runup to submission, somebody knows something, or just plain how hell are we trading at .34 for a ready to submit final BLA to the FDA rally. In a time when big pharma are chomping at the bit for close to market drugs. Who is closer than Telesta? Our data is unimpeachable, our safety is unrivalled by virtually any cancer platform, an FDA panel member said Urocidin ( MCNA) was a much needed treatment for bladder cancer, the only approved refractory to BCG product is Valstar <10% effective. best of all the FDA advised us to submit with current data set and is allowing us to use the 39 patients from our second abandoned (by us) phase 3b trial. That's a compelling story. We should trading well over a buck right now. Anything leading up to the dollar + price range is just noise. GLTA
beech